CAY10575 is primarily utilized in research settings as a selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). By inhibiting sEH, it helps to stabilize epoxyeicosatrienoic acids (EETs), which are known to play a role in reducing inflammation, lowering blood pressure, and protecting against vascular and organ damage. This makes it a valuable tool in studying cardiovascular diseases, inflammatory conditions, and metabolic disorders. Additionally, it is used in preclinical studies to explore its potential therapeutic effects in conditions like diabetes, chronic pain, and neurodegenerative diseases. Its application is crucial in understanding the biological pathways involving sEH and EETs, paving the way for potential drug development.